Literature DB >> 11273900

Reversible posterior leukoencephalopathy in a patient with minimal-change nephrotic syndrome.

M Ikeda1, S Ito, H Hataya, M Honda, K Anbo.   

Abstract

A 9-year-old boy with nephrotic syndrome was transferred to our hospital because of acute renal failure and disturbance of consciousness after high-dose methylprednisolone therapy. He developed severe headache, visual disturbance, and generalized seizures. Brain computed tomography (CT) scan revealed multiple, bilateral, low-density areas in the parieto-occipital lobes. Magnetic resonance imaging (MRI) disclosed a high signal intensity area on T2-weighted images and a low signal intensity area on T1-weighted images in the same lesion. Follow-up brain CT scan and MRI, 2 weeks after the first studies, showed complete resolution of the abnormal lesions, which suggested the diagnosis of reversible posterior leukoencephalopathy syndrome (RPLS). Hypertension and high-dose methylprednisolone administration to the patient in the nephrotic state may be causes of this uncommon syndrome in this case. This is the first report of RPLS in nephrotic syndrome with hypertension not associated with cyclosporine administration.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11273900     DOI: 10.1016/s0272-6386(01)90016-2

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  12 in total

1.  Successful treatment by mycophenolate mofetil in a patient with focal segmental glomerulosclerosis associated with posterior reversible encephalopathy syndrome.

Authors:  Masafumi Tenta; Haruhito Adam Uchida; Tomokazu Nunoue; Ryoko Umebayashi; Yuka Okuyama; Masashi Kitagawa; Yohei Maeshima; Hitoshi Sugiyama; Jun Wada
Journal:  CEN Case Rep       Date:  2014-12-30

2.  Corticosteroid therapy and severity of vasogenic edema in posterior reversible encephalopathy syndrome.

Authors:  Neal S Parikh; Andrew D Schweitzer; Robert J Young; Ashley E Giambrone; John Lyo; Sasan Karimi; Anna Knobel; Ajay Gupta; Babak B Navi
Journal:  J Neurol Sci       Date:  2017-06-29       Impact factor: 3.181

Review 3.  Posterior reversible encephalopathy syndrome in children with kidney disease.

Authors:  Cristina Gavrilovici; Ingrith Miron; Luminiţa Voroneanu; Silvia Bădărau; Magdalena Stârcea
Journal:  Int Urol Nephrol       Date:  2017-08-23       Impact factor: 2.370

4.  Age and gender may affect posterior reversible encephalopathy syndrome in renal disease.

Authors:  Akio Yamada; Norishi Ueda
Journal:  Pediatr Nephrol       Date:  2011-08-07       Impact factor: 3.714

Review 5.  Posterior reversible encephalopathy syndrome in children with kidney diseases.

Authors:  Kenji Ishikura; Yuko Hamasaki; Tomoyuki Sakai; Hiroshi Hataya; Robert H Mak; Masataka Honda
Journal:  Pediatr Nephrol       Date:  2011-05-11       Impact factor: 3.714

6.  Children with posterior reversible encephalopathy syndrome associated with atypical diffusion-weighted imaging and apparent diffusion coefficient.

Authors:  Kenji Ishikura; Yuko Hamasaki; Tomoyuki Sakai; Hiroshi Hataya; Tomohide Goto; Sahoko Miyama; Tatsuo Kono; Masataka Honda
Journal:  Clin Exp Nephrol       Date:  2010-12-10       Impact factor: 2.801

7.  Reversible posterior leukoencephalopathy syndrome secondary to systemic-onset juvenile idiopathic arthritis: A case report and review of the literature.

Authors:  Pingping Zhang; Xiaofeng Li; Yating Li; Jing Wang; Huasong Zeng; Xiaofeng Zeng
Journal:  Biomed Rep       Date:  2014-11-07

Review 8.  [Headache and hypertension. Myth and evidence].

Authors:  T Liman; E Siebert; M Endres
Journal:  Nervenarzt       Date:  2010-08       Impact factor: 1.214

9.  Hypertension induced reversible posterior leukoencephalopathy syndrome: a report of two cases.

Authors:  Z Birsin Ozcakar; Mesiha Ekim; Suat Fitoz; Serap Teber; Selda Hizel; Banu Acar; Selcuk Yüksel; Fatos Yalcinkaya
Journal:  Eur J Pediatr       Date:  2004-12       Impact factor: 3.183

10.  Is reversible posterior leukoencephalopathy with severe hypertension completely reversible in all patients?

Authors:  Narayan Prasad; Sanjeev Gulati; Rakesh Kumar Gupta; Rajesh Kumar; Kumudini Sharma; Raj Kumar Sharma
Journal:  Pediatr Nephrol       Date:  2003-09-19       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.